Company Information

SAMRAT PHARMACHEM LTD.

NSE : NABSE : 530125ISIN CODE : INE103E01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE416.4032.95 (+8.59 %)
PREV CLOSE ( ) 383.45
OPEN PRICE ( ) 380.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 23371
TODAY'S LOW / HIGH ( )377.00 439.00
52 WK LOW / HIGH ( ) 320594
NSE
This Company is not listed in NSE
ChairmanLalit Mehta
Managing DirectorLalit Mehta
Company SecretaryNishant Kankaria
Executive DirectorRajesh Mehta
Megh Mehta
Non Executive Independent DirectorMahendra Pipalia
Samir Kothary
Renu Dharod
Incorporation Year : 1992

Registered Office :

Address : Plot No A2 / 3445,G I D C Phase 4,Opp. P C I Ankleshwar,
Gujarat-393002 .

Phone : 07045456789 / 07046456789

Industry : Pharmaceuticals & Drugs

Listing : BSE,Ahmedabad, Vadodara

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.